Human tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 236-240

  Mighell, Alan J ^a,b   Thompson, John ^a,b   Hume, William J ^b   Markham, Alexander F ^a   Robinson, Philip A ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS DENTAL INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN; NUCLEIC ACID; TENASCIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CELL MIGRATION; HUMAN; HUMAN TISSUE; MORPHOGENESIS; MOUTH CANCER; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; HUMANS; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MOUTH NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TENASCIN;

EID: 0030739277     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<236::AID-IJC6>3.0.CO;2-S     Document Type: Article

References (24)

1. BORSI, L., BALZA, E., CASTELLANI, P., CARNEMOLLA, B., PONASSI, M., QUERZE, G. and ZARDI, L., Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes. Commun., 1, 307-317 (1994).
2. BORSI, L., BALZA, E., GAGGERO, B., ALLEMANNI, G. and ZARDI, L., The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J. Biol. Chem., 270, 6243-6245 (1995).
3. BORSI, L., CARNEMOLLA, B., NICOLÒ, G., SPINA, B., TANARA, G. and ZARDI, L., Expression of different tenascin isoforms in normal, hyperplastic and neoplastic breast tissues. Int. J. Cancer, 52, 688-692 (1992).
4. BORSI, L., CARNEMOLLA, B., PONASSI, M. and ZARDI, L., Steady-state levels of different tenascin mRNAs in various normal tissues. Cell Biol. Int., 17, 325-329 (1993).
5. CARTER, D.H., SLOAN, P. and AARON, J.E., Immunolocalisation of collagen types I and III, tenascin, and fibronectin in intramembranous bone. J. Histochem. Cytochem., 39, 599-606 (1991).
6. CHIQUET-EHRISMANN, R., HAGIOS, C. and MATSUMOTO, K., The tenascin gene family. Perspect. Develop. Neurobiol., 2, 3-7 (1994).
7. DÖRRIES, U. and SCHACHNER, M., Tenascin mRNA isoforms in the developing mouse brain. J. Neurosci. Res., 37, 336-347 (1994).
8. ERICKSON, H.P., Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol., 5, 869-876 (1993).
9. ERICKSON, H.P., Evolution of the tenascin family - implications for function of the C-terminal fibrinogen-like domain. Perspect. Develop. Biol., 2, 9-19 (1994).
10. JULIAN, J., CHIQUET-EHRISMANN, R., ERICKSON, H.P. and CARSON, D.D., Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion. Development, 120, 661-671 (1994).
11. LIGHTNER, V.A., Tenascin: does it play a role in epidermal morphogenesis and homeostasis? J. invest. Dermatol., 102, 273-277 (1994).
12. LIGHTNER, V.A., MARKS, J.R. and MCCACHREN, S.S., Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp. Cell Res., 210, 177-184 (1994).
13. LUOMANEN, M. and VIRTANEN, I., Distribution of tenascin in healing incision, excision and laser wounds. J. Oral Pathol. Med., 22, 41-45
14. MACKIE, E.J. and TUCKER, R.P., Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J. Cell Sci., 103, 765-771 (1992).
15. QIAN, L. and WILKINSON, M., DNA fragment purification: removal of agarose 10 minutes after electrophoresis. BioTechniques, 10, 736-738 (1991).
16. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual (2nd ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
17. SCHWOGLER, S., ODENTHAL, M., MEYER ZUM BUSCHENFELDE, K.H. and RAMADORI, G., Alternative splicing products of the tenascin gene distinguish rat liver fat storing cells from arterial smooth muscle cells and skin fibroblasts. Biochem. Biophys. Res. Commun., 185, 768-775 (1992).
18. SHRESTHA, P., SAKAMOTO, F., TAKAGI, H., YAMADA, T. and MORI, M., Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study. Europ. J. Cancer Oral Oncol. 30B, 132-137 (1995).
19. SIRI, A., CARNEMOLLA, B., SAGINATI, M., LEPRINI, A., CASARI, G., BARALLE, F. and ZARDI, L., Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Res., 19, 525-531 (1991).
20. SRIRAMARAO, P. and BOURDON, M.A., A novel type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res., 21, 163-168 (1993).
21. STEINDLER, D.A., SETTLES, D., ERICKSON, H.P., LAYWELL, E.D., YOSHIKI, A., FAISSNER, A. and KUSAKABE, M., Tenascin knockout mice: barrels, boundary molecules, and glial scars. J. Neurosci., 15, 1971-1983 (1995).
22. TUCKER, R.P., The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development, 117, 347-358 (1993).
23. TUCKER, R.P., SPRING, J., BAUMGARTNER, S., MARTIN, D., HAGIOS, C., POSS, P.M. and CHIQUET-EHRISMANN, R., Novel tenascin variants with a distinctive pattern of expression in the avian embryo. Development, 120, 637-647 (1994).
24. ZHAO, Y. and YOUNG, S.L., TGF-β regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Amer. J. Physiol., 268, L173-L180 (1995).